BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36208592)

  • 1. Computational analysis of natural product B-Raf inhibitors.
    Chettri S; Sasmal P; Adon T; Sajeev Kumar B; Kumar BP; Raghavendra NM
    J Mol Graph Model; 2023 Jan; 118():108340. PubMed ID: 36208592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
    Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insight parameter drug design for human β-tryptase inhibition integrated molecular docking, QSAR, molecular dynamics simulation, and pharmacophore modelling studies of α-keto-[1,2,4]-oxadiazoles.
    Yu CX; Tan JW; Rullah K; Imran S; Tham CL
    J Biomol Struct Dyn; 2023; 41(22):12978-12996. PubMed ID: 36709457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Four New Chemical Series of Small Drug-Like Natural Products as Potential Neuropilin-1 Inhibitors by Structure-Based Virtual Screening: Pharmacophore-Based Molecular Docking and Dynamics Simulation.
    Sabki A; Khelifi L; Kameli A; Baali S
    Chem Biodivers; 2023 Mar; 20(3):e202200933. PubMed ID: 36799050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational Exploration of Anti-Cancer Potential of GUAIANE Dimers from
    Shams Ul Hassan S; Abbas SQ; Hassan M; Jin HZ
    Anticancer Agents Med Chem; 2022; 22(4):731-746. PubMed ID: 34645380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target-based virtual screening, computational multiscoring docking and molecular dynamics simulation of small molecules as promising drug candidate affecting kinesin-like protein KIFC1.
    Khan MKA; Ahmad S; Rabbani G; Shahab U; Khan MS
    Cell Biochem Funct; 2022 Jul; 40(5):451-472. PubMed ID: 35758564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based pharmacophore modeling, virtual screening and simulation studies for the identification of potent anticancerous phytochemical lead targeting cyclin-dependent kinase 2.
    Sharma M; Sharma N; Muddassir M; Rahman QI; Dwivedi UN; Akhtar S
    J Biomol Struct Dyn; 2022; 40(20):9815-9832. PubMed ID: 34151738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated computational approach for
    Kuchana V; Kashetti V; Peddi SKR; Sivan S; Manga V
    J Recept Signal Transduct Res; 2022 Oct; 42(5):439-453. PubMed ID: 34844526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico identification of novel kinase inhibitors by targeting B-Raf(v660e) from natural products database.
    Wang ZJ; Wan ZN; Chen XD; Wu CF; Gao GL; Liu R; Shi Z; Bao JK
    J Mol Model; 2015 Apr; 21(4):102. PubMed ID: 25832798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
    Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacophore-Based Screening, Molecular Docking, and Dynamic Simulation of Fungal Metabolites as Inhibitors of Multi-Targets in Neurodegenerative Disorders.
    Iqbal D; Alsaweed M; Jamal QMS; Asad MR; Rizvi SMD; Rizvi MR; Albadrani HM; Hamed M; Jahan S; Alyenbaawi H
    Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of compounds derived from the Chinese medicinal formula Huangqi Guizhi Wuwu Tang with stroke-related numbness and weakness targets: An in-silico docking and molecular dynamics study.
    Lee S; Wong AR; Yang AWH; Hung A
    Comput Biol Med; 2022 Jul; 146():105568. PubMed ID: 35508083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational assessment of chemicals from
    Ugwah-Oguejiofor CJ; Chukwuka EP; Onifade OF; Agu ST; Adegboyega AE; Johnson GI; Ogunsuyi OI; Johnson TO
    J Biomol Struct Dyn; 2023; 41(22):13271-13286. PubMed ID: 36709454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the Ras/Raf/extracellular signal-regulated kinase 1/2 signaling pathway by compounds of natural origin for possible treatment of spinal cord injury: An
    Yan S; Zhang L; Wang S; Wu T; Gong Z
    Exp Ther Med; 2018 Mar; 15(3):2860-2868. PubMed ID: 29456689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacophore-based virtual screening approach for identification of potent natural modulatory compounds of human Toll-like receptor 7.
    Gupta CL; Babu Khan M; Ampasala DR; Akhtar S; Dwivedi UN; Bajpai P
    J Biomol Struct Dyn; 2019 Nov; 37(18):4721-4736. PubMed ID: 30661449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel natural drug candidates against BRAF mutated carcinoma; An integrative in-silico structure-based pharmacophore modeling and virtual screening process.
    Dain Md Opo FA; Alsaiari AA; Rahman Molla MH; Ahmed Sumon MA; Yaghmour KA; Ahammad F; Mohammad F; Simal-Gandara J
    Front Chem; 2022; 10():986376. PubMed ID: 36267655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtual Screening for Potential Inhibitors of Human Hexokinase II for the Development of Anti-Dengue Therapeutics.
    Tanbin S; Ahmad Fuad FA; Abdul Hamid AA
    BioTech (Basel); 2020 Dec; 10(1):. PubMed ID: 35822774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of EGFR inhibitors as potential agents for cancer therapy: pharmacophore-based modeling, molecular docking, and molecular dynamics investigations.
    Ashiru MA; Ogunyemi SO; Temionu OR; Ajibare AC; Cicero-Mfon NC; Ihekuna OA; Jagun MO; Abdulmumin L; Adisa QK; Asibor YE; Okorie CJ; Lawal MO; Babalola MO; Abdulrasaq IT; Salau LB; Olatunji IO; Bankole MA; Daud AB; Adeyemi AO
    J Mol Model; 2023 Apr; 29(5):128. PubMed ID: 37016200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of binding mechanism of triclosan towards cancer markers using molecular docking and molecular dynamics.
    Bhardwaj P; Biswas GP; Mahata N; Ghanta S; Bhunia B
    Chemosphere; 2022 Apr; 293():133550. PubMed ID: 34999105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.